Randomized phase II study of preoperative letrozole (Femara) in combination with avastin [bavacizumab] in hormone receptor positive breast cancer.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Bevacizumab (Primary) ; Letrozole (Primary)
- Indications Advanced breast cancer; Breast cancer
- Focus Therapeutic Use
- 22 Feb 2021 Status changed from recruiting to discontinued.
- 16 Jun 2009 Novartis and Genentech added as trial sponsor as reported by ClinicalTrials.gov.
- 16 Jun 2009 Planned end date changed from 1 Dec 2009 to 1 May 2010 as reported by ClinicalTrials.gov.